Role of sirtuins in ischemia-reperfusion injury

World Journal of Gastroenterology

Volumn 19, Issue 43, 2013, Pages 7594-7602

  Pantazi, Eirini ^a   Zaouali, Mohamed Amine ^a   Bejaoui, Mohamed ^a   Folch Puy, Emma ^a   Abdennebi, Hassen Ben ^b   Roselló Catafau, Joan ^a  

^a INST D INVESTIGACIONS B   (Spain)

^b Research Unit of Biology and Molecular Anthropology Applied to Development and Health   (Tunisia)

Author keywords

Apoptosis; Ischemia reperfusion injury; Oxidative stress; Sirtuin 1; Sirtuin 3

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SIRTUIN; SIRTUIN 1; SIRTUIN 3; TRANSCRIPTION FACTOR FOXO; UNCOUPLING PROTEIN 2;

APOPTOSIS; CELL PROTECTION; CELL STRESS; HOMEOSTASIS; HUMAN; HYPOXIA; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN INTERACTION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

APOPTOSIS; ISCHEMIA-REPERFUSION INJURY; OXIDATIVE STRESS; SIRTUIN 1; SIRTUIN 3;

ANIMALS; APOPTOSIS; CELL SURVIVAL; ENERGY METABOLISM; HUMANS; INFLAMMATION; OXIDATIVE STRESS; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SIRTUIN 1; SIRTUIN 3; SIRTUINS;

EID: 84888118453     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i43.7594     Document Type: Review

References (101)

1. Nakagawa T, Guarente L. Sirtuins at a glance. J Cell Sci 2011; 124: 833-838 [PMID: 21378304 DOI: 10.1242/jcs.081067]
2. Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R, Sinclair DA. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004; 305: 390-392 [PMID: 15205477 DOI: 10.1126/science.1099196]
3. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005; 434: 113-118 [PMID: 15744310 DOI: 10.1038/nature03354]
4. Morris KC, Lin HW, Thompson JW, Perez-Pinzon MA. Pathways for ischemic cytoprotection: role of sirtuins in caloric restriction, resveratrol, and ischemic preconditioning. J Cereb Blood Flow Metab 2011; 31: 1003-1019 [PMID: 21224864 DOI: 10.1038/jcbfm.2010.229]
5. Nogueiras R, Habegger KM, Chaudhary N, Finan B, Banks AS, Dietrich MO, Horvath TL, Sinclair DA, Pfluger PT, Tschöp MH. Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. Physiol Rev 2012; 92: 1479-1514 [PMID: 22811431 DOI: 10.1152/physrev.00022.2011]
6. Pillarisetti S. A review of Sirt1 and Sirt1 modulators in cardiovascular and metabolic diseases. Recent Pat Cardiovasc Drug Discov 2008; 3: 156-164 [PMID: 18991791]
7. Gorenne I, Kumar S, Gray K, Figg N, Yu H, Mercer J, Bennett M. Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis. Circulation 2013; 127: 386-396 [PMID: 23224247 DOI: 10.1161/CIRCULATIONAHA. 112.124404]
8. Al Massadi O, Quiñones M, Lear P, Dieguez C, Nogueiras R. The Brain: A New Organ for the Metabolic Actions of SIRT1. Horm Metab Res 2013 Aug 15; Epub ahead of print [PMID: 23950036 DOI: 10.1055/s-0033-1351322]
9. Gillum MP, Kotas ME, Erion DM, Kursawe R, Chatterjee P, Nead KT, Muise ES, Hsiao JJ, Frederick DW, Yonemitsu S, Banks AS, Qiang L, Bhanot S, Olefsky JM, Sears DD, Caprio S, Shulman GI. SirT1 regulates adipose tissue inflammation. Diabetes 2011; 60: 3235-3245 [PMID: 22110092 DOI: 10.2337/ db11-0616]
10. Brenmoehl J, Hoeflich A. Dual control of mitochondrial biogenesis by sirtuin 1 and sirtuin 3. Mitochondrion 2013 Apr 11; Epub ahead of print [PMID: 23583953 DOI: 10.1016/ j.mito.2013.04.002]
11. Rardin MJ, Newman JC, Held JM, Cusack MP, Sorensen DJ, Li B, Schilling B, Mooney SD, Kahn CR, Verdin E, Gibson BW. Label-free quantitative proteomics of the lysine acetylome in mitochondria identifies substrates of SIRT3 in metabolic pathways. Proc Natl Acad Sci USA 2013; 110: 6601-6606 [PMID: 23576753 DOI: 10.1073/pnas.1302961110]
12. Casillas-Ramírez A, Mosbah IB, Ramalho F, Roselló-Catafau J, Peralta C. Past and future approaches to ischemiareperfusion lesion associated with liver transplantation. Life Sci 2006; 79: 1881-1894 [PMID: 16828807 DOI: 10.1016/ j.lfs.2006.06.024]
13. Treska V, Kobr J, Hasman D, Racek J, Trefil L, Reischig T, Hes O, Kuntscher V, Molacek J, Treska I. Ischemia-reperfusion injury in kidney transplantation from non-heart-beating donor--do antioxidants or antiinflammatory drugs play any role? Bratisl Lek Listy 2009; 110: 133-136 [PMID: 19507631]
14. Schemmer P, Lemasters JJ, Clavien PA. Ischemia/Reperfusion injury in liver surgery and transplantation. HPB Surg 2012; 2012: 453295 [PMID: 23345924 DOI: 10.1155/2012/453295]
15. Czubkowski P, Socha P, Pawlowska J. Oxidative stress in liver transplant recipients. Ann Transplant 2011; 16: 99-108 [PMID: 21436783]
16. Datta G, Fuller BJ, Davidson BR. Molecular mechanisms of liver ischemia reperfusion injury: insights from transgenic knockout models. World J Gastroenterol 2013; 19: 1683-1698 [PMID: 23555157 DOI: 10.3748/wjg.v19.i11.1683]
17. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 2008; 88: 581-609 [PMID: 18391174 DOI: 10.1152/physrev. 00024.2007]
18. Ruderman NB, Xu XJ, Nelson L, Cacicedo JM, Saha AK, Lan F, Ido Y. AMPK and SIRT1: a long-standing partnership? Am J Physiol Endocrinol Metab 2010; 298: E751-E760 [PMID: 20103737 DOI: 10.1152/ajpendo.00745.2009]
19. Suchankova G, Nelson LE, Gerhart-Hines Z, Kelly M, Gauthier MS, Saha AK, Ido Y, Puigserver P, Ruderman NB. Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells. Biochem Biophys Res Commun 2009; 378: 836-841 [PMID: 19071085 DOI: 10.1016/ j.bbrc.2008.11.130]
20. Lempiäinen J, Finckenberg P, Levijoki J, Mervaala E. AMPK activator AICAR ameliorates ischaemia reperfusion injury in the rat kidney. Br J Pharmacol 2012; 166: 1905-1915 [PMID: 22324445 DOI: 10.1111/j.1476-5381.2012.01895.x]
21. Della-Morte D, Dave KR, DeFazio RA, Bao YC, Raval AP, Perez-Pinzon MA. Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 2009; 159: 993-1002 [PMID: 19356683 DOI: 10.1016/j.neuroscience.2009.01.017]
22. Dioum EM, Chen R, Alexander MS, Zhang Q, Hogg RT, Gerard RD, Garcia JA. Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1. Science 2009; 324: 1289-1293 [PMID: 19498162 DOI: 10.1126/science.1169956]
23. Lim JH, Lee YM, Chun YS, Chen J, Kim JE, Park JW. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol Cell 2010; 38: 864-878 [PMID: 20620956 DOI: 10.1016/j.molcel.2010.05.023]
24. Majmundar AJ, Wong WJ, Simon MC. Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 2010; 40: 294-309 [PMID: 20965423 DOI: 10.1016/j.molcel.2010.09.022]
25. Zhong L, D'Urso A, Toiber D, Sebastian C, Henry RE, Vadysirisack DD, Guimaraes A, Marinelli B, Wikstrom JD, Nir T, Clish CB, Vaitheesvaran B, Iliopoulos O, Kurland I, Dor Y, Weissleder R, Shirihai OS, Ellisen LW, Espinosa JM, Mostoslavsky R. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 2010; 140: 280-293 [PMID: 20141841 DOI: 10.1016/j.cell.2009.12.041]
26. Bell EL, Emerling BM, Ricoult SJ, Guarente L. SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production. Oncogene 2011; 30: 2986-2996 [PMID: 21358671 DOI: 10.1038/onc.2011.37]
27. Finley LW, Carracedo A, Lee J, Souza A, Egia A, Zhang J, Teruya-Feldstein J, Moreira PI, Cardoso SM, Clish CB, Pandolfi PP, Haigis MC. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. Cancer Cell 2011; 19: 416-428 [PMID: 21397863 DOI: 10.1016/ j.ccr.2011.02.014]
28. Nemoto S, Fergusson MM, Finkel T. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. J Biol Chem 2005; 280: 16456-16460 [PMID: 15716268 DOI: 10.1074/jbc.M501485200]
29. Chen SD, Lin TK, Yang DI, Lee SY, Shaw FZ, Liou CW, Chuang YC. Protective effects of peroxisome proliferatoractivated receptors gamma coactivator-1alpha against neuronal cell death in the hippocampal CA1 subfield after transient global ischemia. J Neurosci Res 2010; 88: 605-613 [PMID: 19774674 DOI: 10.1002/jnr.22225]
30. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jäger S, Handschin C, Zheng K, Lin J, Yang W, Simon DK, Bachoo R, Spiegelman BM. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006; 127: 397-408 [PMID: 17055439 DOI: 10.1016/ j.cell.2006.09.024]
31. Shin JA, Lee KE, Kim HS, Park EM. Acute resveratrol treatment modulates multiple signaling pathways in the ischemic brain. Neurochem Res 2012; 37: 2686-2696 [PMID: 22878646 DOI: 10.1007/s11064-012-0858-2]
32. Mattiasson G, Shamloo M, Gido G, Mathi K, Tomasevic G, Yi S, Warden CH, Castilho RF, Melcher T, Gonzalez-Zulueta M, Nikolich K, Wieloch T. Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nat Med 2003; 9: 1062-1068 [PMID: 12858170 DOI: 10.1038/nm903]
33. McLeod CJ, Aziz A, Hoyt RF, McCoy JP, Sack MN. Uncoupling proteins 2 and 3 function in concert to augment tolerance to cardiac ischemia. J Biol Chem 2005; 280: 33470-33476 [PMID: 16079144 DOI: 10.1074/jbc.M505258200]
34. de Bilbao F, Arsenijevic D, Vallet P, Hjelle OP, Ottersen OP, Bouras C, Raffin Y, Abou K, Langhans W, Collins S, Plamondon J, Alves-Guerra MC, Haguenauer A, Garcia I, Richard D, Ricquier D, Giannakopoulos P. Resistance to cerebral ischemic injury in UCP2 knockout mice: evidence for a role of UCP2 as a regulator of mitochondrial glutathione levels. J Neurochem 2004; 89: 1283-1292 [PMID: 15147521 DOI: 10.1111/j.1471-4159.2004.02432.x]
35. Bodyak N, Rigor DL, Chen YS, Han Y, Bisping E, Pu WT, Kang PM. Uncoupling protein 2 modulates cell viability in adult rat cardiomyocytes. Am J Physiol Heart Circ Physiol 2007; 293: H829-H835 [PMID: 17468330 DOI: 10.1152/ajpheart. 01409.2006]
36. Sanderson TH, Reynolds CA, Kumar R, Przyklenk K, Hüttemann M. Molecular mechanisms of ischemia-reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation. Mol Neurobiol 2013; 47: 9-23 [PMID: 23011809 DOI: 10.1007/s12035-012-8344-z]
37. Rodrigo R, Prieto JC, Castillo R. Cardioprotection against ischaemia/reperfusion by vitamins C and E plus n-3 fatty acids: molecular mechanisms and potential clinical applications. Clin Sci (Lond) 2013; 124: 1-15 [PMID: 22963444 DOI: 10.1042/CS20110663]
38. Raedschelders K, Ansley DM, Chen DD. The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion. Pharmacol Ther 2012; 133: 230-255 [PMID: 22138603 DOI: 10.1016/j.pharmthe ra.2011.11.004]
39. Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, Yu X, Tian B, Wagner T, Vatner SF, Sadoshima J. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 2007; 100: 1512-1521 [PMID: 17446436 DOI: 10.1161/01. RES.0000267723.65696.4a]
40. Vinciguerra M, Santini MP, Martinez C, Pazienza V, Claycomb WC, Giuliani A, Rosenthal N. mIGF-1/JNK1/SirT1 signaling confers protection against oxidative stress in the heart. Aging Cell 2012; 11: 139-149 [PMID: 22051242 DOI: 10.1111/j.1474-9726.2011.00766.x]
41. Hsu CP, Zhai P, Yamamoto T, Maejima Y, Matsushima S, Hariharan N, Shao D, Takagi H, Oka S, Sadoshima J. Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation 2010; 122: 2170-2182 [PMID: 21060073 DOI: 10.1161/CIRCULATIONAHA.110.958033]
42. Daitoku H, Hatta M, Matsuzaki H, Aratani S, Ohshima T, Miyagishi M, Nakajima T, Fukamizu A. Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc Natl Acad Sci USA 2004; 101: 10042-10047 [PMID: 15220471 DOI: 10.1073/ pnas.0400593101]
43. Hasegawa K, Wakino S, Yoshioka K, Tatematsu S, Hara Y, Minakuchi H, Sueyasu K, Washida N, Tokuyama H, Tzukerman M, Skorecki K, Hayashi K, Itoh H. Kidney-specific overexpression of Sirt1 protects against acute kidney injury by retaining peroxisome function. J Biol Chem 2010; 285: 13045-13056 [PMID: 20139070 DOI: 10.1074/jbc.M109.067728]
44. Lombard DB, Alt FW, Cheng HL, Bunkenborg J, Streeper RS, Mostoslavsky R, Kim J, Yancopoulos G, Valenzuela D, Murphy A, Yang Y, Chen Y, Hirschey MD, Bronson RT, Haigis M, Guarente LP, Farese RV, Weissman S, Verdin E, Schwer B. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol 2007; 27: 8807-8814 [PMID: 17923681 DOI: 10.1128/MCB.01636-07]
45. Chen Y, Zhang J, Lin Y, Lei Q, Guan KL, Zhao S, Xiong Y. Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS. EMBO Rep 2011; 12: 534-541 [PMID: 21566644 DOI: 10.1038/embor. 2011.65]
46. Qiu X, Brown K, Hirschey MD, Verdin E, Chen D. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 2010; 12: 662-667 [PMID: 21109198 DOI: 10.1016/j.cmet.2010.11.015]
47. Zhao S, Xu W, Jiang W, Yu W, Lin Y, Zhang T, Yao J, Zhou L, Zeng Y, Li H, Li Y, Shi J, An W, Hancock SM, He F, Qin L, Chin J, Yang P, Chen X, Lei Q, Xiong Y, Guan KL. Regulation of cellular metabolism by protein lysine acetylation. Science 2010; 327: 1000-1004 [PMID: 20167786 DOI: 10.1126/science. 1179689]
48. Someya S, Yu W, Hallows WC, Xu J, Vann JM, Leeuwenburgh C, Tanokura M, Denu JM, Prolla TA. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 2010; 143: 802-812 [PMID: 21094524 DOI: 10.1016/j.cell.2010.10.002]
49. Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009; 325: 834-840 [PMID: 19608861 DOI: 10.1126/science. 1175371]
50. Palacios OM, Carmona JJ, Michan S, Chen KY, Manabe Y, Ward JL, Goodyear LJ, Tong Q. Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle. Aging (Albany NY) 2009; 1: 771-783 [PMID: 20157566]
51. Sundaresan NR, Gupta M, Kim G, Rajamohan SB, Isbatan A, Gupta MP. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest 2009; 119: 2758-2771 [PMID: 19652361 DOI: 10.1172/JCI39162]
52. Jacobs KM, Pennington JD, Bisht KS, Aykin-Burns N, Kim HS, Mishra M, Sun L, Nguyen P, Ahn BH, Leclerc J, Deng CX, Spitz DR, Gius D. SIRT3 interacts with the daf-16 homolog FOXO3a in the mitochondria, as well as increases FOXO3a dependent gene expression. Int J Biol Sci 2008; 4: 291-299 [PMID: 18781224]
53. Kong X, Wang R, Xue Y, Liu X, Zhang H, Chen Y, Fang F, Chang Y. Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS One 2010; 5: e11707 [PMID: 20661474 DOI: 10.1371/journal.pone.0011707]
54. Andrews DT, Royse C, Royse AG. The mitochondrial permeability transition pore and its role in anaesthesia-triggered cellular protection during ischaemia-reperfusion injury. Anaesth Intensive Care 2012; 40: 46-70 [PMID: 22313063]
55. Halestrap AP. Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans 2006; 34: 232-237 [PMID: 16545083 DOI: 10.1042/BST20060232]
56. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection. Cardiovasc Res 2004; 61: 372-385 [PMID: 14962470 DOI: 10.1016/ S0008-6363(03)00533-9]
57. Shahzad T, Kasseckert SA, Iraqi W, Johnson V, Schulz R, Schlüter KD, Dörr O, Parahuleva M, Hamm C, Ladilov Y, Abdallah Y. Mechanisms involved in postconditioning protection of cardiomyocytes against acute reperfusion injury. J Mol Cell Cardiol 2013; 58: 209-216 [PMID: 23328483 DOI: 10.1016/j.yjmcc.2013.01.003]
58. Hafner AV, Dai J, Gomes AP, Xiao CY, Palmeira CM, Rosenzweig A, Sinclair DA. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging (Albany NY) 2010; 2: 914-923 [PMID: 21212461]
59. Ahuja N, Schwer B, Carobbio S, Waltregny D, North BJ, Castronovo V, Maechler P, Verdin E. Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. J Biol Chem 2007; 282: 33583-33592 [PMID: 17715127 DOI: 10.1074/jbc.M705488200]
60. Schlicker C, Gertz M, Papatheodorou P, Kachholz B, Becker CF, Steegborn C. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J Mol Biol 2008; 382: 790-801 [PMID: 18680753 DOI: 10.1016/ j.jmb.2008.07.048]
61. Eltzschig HK, Collard CD. Vascular ischaemia and reperfusion injury. Br Med Bull 2004; 70: 71-86 [PMID: 15494470 DOI: 10.1093/bmb/ldh025]
62. Schmitt CA, Heiss EH, Dirsch VM. Effect of resveratrol on endothelial cell function: Molecular mechanisms. Biofactors 2010; 36: 342-349 [PMID: 20730905 DOI: 10.1002/biof.109]
63. Ota H, Eto M, Ogawa S, Iijima K, Akishita M, Ouchi Y. SIRT1/eNOS axis as a potential target against vascular senescence, dysfunction and atherosclerosis. J Atheroscler Thromb 2010; 17: 431-435 [PMID: 20215708]
64. Donato AJ, Magerko KA, Lawson BR, Durrant JR, Lesniewski LA, Seals DR. SIRT-1 and vascular endothelial dysfunction with ageing in mice and humans. J Physiol 2011; 589: 4545-4554 [PMID: 21746786 DOI: 10.1113/jphysiol. 2011.211219]
65. Mattagajasingh I, Kim CS, Naqvi A, Yamamori T, Hoffman TA, Jung SB, DeRicco J, Kasuno K, Irani K. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci USA 2007; 104: 14855-14860 [PMID: 17785417 DOI: 10.1073/ pnas.0704329104]
66. Nadtochiy SM, Yao H, McBurney MW, Gu W, Guarente L, Rahman I, Brookes PS. SIRT1-mediated acute cardioprotection. Am J Physiol Heart Circ Physiol 2011; 301: H1506-H1512 [PMID: 21856913 DOI: 10.1152/ajpheart.00587.2011]
67. Dong W, Li F, Pan Z, Liu S, Yu H, Wang X, Bi S, Zhang W. Resveratrol ameliorates subacute intestinal ischemia-reperfusion injury. J Surg Res 2013; 185: 182-189 [PMID: 23735732 DOI: 10.1016/j.jss.2013.05.013]
68. Liu JC, Chen JJ, Chan P, Cheng CF, Cheng TH. Inhibition of cyclic strain-induced endothelin-1 gene expression by resveratrol. Hypertension 2003; 42: 1198-1205 [PMID: 14623829]
69. Zou JG, Wang ZR, Huang YZ, Cao KJ, Wu JM. Effect of red wine and wine polyphenol resveratrol on endothelial function in hypercholesterolemic rabbits. Int J Mol Med 2003; 11: 317-320 [PMID: 12579333]
70. Liu Z, Song Y, Zhang X, Liu Z, Zhang W, Mao W, Wang W, Cui W, Zhang X, Jia X, Li N, Han C, Liu C. Effects of transresveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model. Clin Exp Pharmacol Physiol 2005; 32: 1049-1054 [PMID: 16445570 DOI: 10.1111/j.1440-1681.2005.04303.x]
71. Yang J, Wang N, Li J, Zhang J, Feng P. Effects of resveratrol on NO secretion stimulated by insulin and its dependence on SIRT1 in high glucose cultured endothelial cells. Endocrine 2010; 37: 365-372 [PMID: 20960276 DOI: 10.1007/ s12020-010-9314-8]
72. Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/reperfusion injury--a fresh look. Exp Mol Pathol 2003; 74: 86-93 [PMID: 12710939]
73. Stein S, Matter CM. Protective roles of SIRT1 in atherosclerosis. Cell Cycle 2011; 10: 640-647 [PMID: 21293192 DOI: 10.4161/cc.10.4.14863]
74. Stein S, Schäfer N, Breitenstein A, Besler C, Winnik S, Lohmann C, Heinrich K, Brokopp CE, Handschin C, Landmesser U, Tanner FC, Lüscher TF, Matter CM. SIRT1 reduces endothelial activation without affecting vascular function in ApoE-/-mice. Aging (Albany NY) 2010; 2: 353-360 [PMID: 20606253]
75. Hernández-Jiménez M, Hurtado O, Cuartero MI, Ballesteros I, Moraga A, Pradillo JM, McBurney MW, Lizasoain I, Moro MA. Silent information regulator 1 protects the brain against cerebral ischemic damage. Stroke 2013; 44: 2333-2337 [PMID: 23723308 DOI: 10.1161/STROKEAHA.113.001715]
76. Kosieradzki M, Rowiński W. Ischemia/reperfusion injury in kidney transplantation: mechanisms and prevention. Transplant Proc 2008; 40: 3279-3288 [PMID: 19100373 DOI: 10.1016/j.transproceed.2008.10.004]
77. Bordone L, Cohen D, Robinson A, Motta MC, van Veen E, Czopik A, Steele AD, Crowe H, Marmor S, Luo J, Gu W, Guarente L. SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 2007; 6: 759-767 [PMID: 17877786 DOI: 10.1111/j.1474-9726.2007.00335.x]
78. Satoh A, Brace CS, Rensing N, Cliften P, Wozniak DF, Herzog ED, Yamada KA, Imai S. Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. Cell Metab 2013; 18: 416-430 [PMID: 24011076 DOI: 10.1016/j.cmet.2013.07.013]
79. Radak Z, Koltai E, Taylor AW, Higuchi M, Kumagai S, Ohno H, Goto S, Boldogh I. Redox-regulating sirtuins in aging, caloric restriction, and exercise. Free Radic Biol Med 2013; 58: 87-97 [PMID: 23339850 DOI: 10.1016/j.freeradbiomed.2013.01.004]
80. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001; 107: 149-159 [PMID: 11672523]
81. Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, Patel P, Bronson R, Appella E, Alt FW, Chua KF. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA 2003; 100: 10794-10799 [PMID: 12960381 DOI: 10.1073/pnas.1934713100]
82. Anekonda TS, Adamus G. Resveratrol prevents antibodyinduced apoptotic death of retinal cells through upregulation of Sirt1 and Ku70. BMC Res Notes 2008; 1: 122 [PMID: 19046449 DOI: 10.1186/1756-0500-1-122]
83. Jeong J, Juhn K, Lee H, Kim SH, Min BH, Lee KM, Cho MH, Park GH, Lee KH. SIRT1 promotes DNA repair activity and deacetylation of Ku70. Exp Mol Med 2007; 39: 8-13 [PMID: 17334224]
84. Fan H, Yang HC, You L, Wang YY, He WJ, Hao CM. The histone deacetylase, SIRT1, contributes to the resistance of young mice to ischemia/reperfusion-induced acute kidney injury. Kidney Int 2013; 83: 404-413 [PMID: 23302720 DOI: 10.1038/ki.2012.394]
85. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004; 303: 2011-2015 [PMID: 14976264 DOI: 10.1126/science.1094637]
86. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004; 23: 2369-2380 [PMID: 15152190 DOI: 10.1038/ sj.emboj.7600244]
87. Zhao G, Ma H, Shen X, Xu GF, Zhu YL, Chen B, Tie R, Qu P, Lv Y, Zhang H, Yu J. Role of glycogen synthase kinase 3β in protective effect of propofol against hepatic ischemia-reperfusion injury. J Surg Res 2013; 185: 388-398 [PMID: 23743186 DOI: 10.1016/j.jss.2013.05.004]
88. Cui J, Li Z, Qian LB, Gao Q, Wang J, Xue M, Lou XE, Bruce IC, Xia Q, Wang HP. Reducing the oxidative stress mediates the cardioprotection of bicyclol against ischemia-reperfusion injury in rats. J Zhejiang Univ Sci B 2013; 14: 487-495 [PMID: 23733425 DOI: 10.1631/jzus.B1200263]
89. Chen CJ, Fu YC, Yu W, Wang W. SIRT3 protects cardiomyocytes from oxidative stress-mediated cell death by activating NF-κB. Biochem Biophys Res Commun 2013; 430: 798-803 [PMID: 23201401 DOI: 10.1016/j.bbrc.2012.11.066]
90. Pellegrini L, Pucci B, Villanova L, Marino ML, Marfe G, Sansone L, Vernucci E, Bellizzi D, Reali V, Fini M, Russo MA, Tafani M. SIRT3 protects from hypoxia and staurosporinemediated cell death by maintaining mitochondrial membrane potential and intracellular pH. Cell Death Differ 2012; 19: 1815-1825 [PMID: 22595756 DOI: 10.1038/cdd.2012.62]
91. Cheng Y, Ren X, Gowda AS, Shan Y, Zhang L, Yuan YS, Patel R, Wu H, Huber-Keener K, Yang JW, Liu D, Spratt TE, Yang JM. Interaction of Sirt3 with OGG1 contributes to repair of mitochondrial DNA and protects from apoptotic cell death under oxidative stress. Cell Death Dis 2013; 4: e731 [PMID: 23868064 DOI: 10.1038/cddis.2013.254]
92. Yang H, Yang T, Baur JA, Perez E, Matsui T, Carmona JJ, Lamming DW, Souza-Pinto NC, Bohr VA, Rosenzweig A, de Cabo R, Sauve AA, Sinclair DA. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 2007; 130: 1095-1107 [PMID: 17889652 DOI: 10.1016/j.cell.2007.07.035]
93. Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD, van der Meer R, Nguyen P, Savage J, Owens KM, Vassilopoulos A, Ozden O, Park SH, Singh KK, Abdulkadir SA, Spitz DR, Deng CX, Gius D. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 2010; 17: 41-52 [PMID: 20129246 DOI: 10.1016/j.ccr.2009.11.023]
94. Allison SJ, Milner J. SIRT3 is pro-apoptotic and participates in distinct basal apoptotic pathways. Cell Cycle 2007; 6: 2669-2677 [PMID: 17957139 DOI: 10.4161/cc.6.21.4866]
95. Shi T, Fan GQ, Xiao SD. SIRT3 reduces lipid accumulation via AMPK activation in human hepatic cells. J Dig Dis 2010; 11: 55-62 [PMID: 20132432 DOI: 10.1111/ j.1751-2980.2009.00416.x]
96. Purushotham A, Schug TT, Xu Q, Surapureddi S, Guo X, Li X. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab 2009; 9: 327-338 [PMID: 19356714 DOI: 10.1016/ j.cmet.2009.02.006]
97. Raval AP, Dave KR, Pérez-Pinzón MA. Resveratrol mimics ischemic preconditioning in the brain. J Cereb Blood Flow Metab 2006; 26: 1141-1147 [PMID: 16395277 DOI: 10.1038/ sj.jcbfm.9600262]
98. Nadtochiy SM, Redman E, Rahman I, Brookes PS. Lysine deacetylation in ischaemic preconditioning: the role of SIRT1. Cardiovasc Res 2011; 89: 643-649 [PMID: 20823277 DOI: 10.1093/cvr/cvq287]
99. Rane S, He M, Sayed D, Vashistha H, Malhotra A, Sadoshima J, Vatner DE, Vatner SF, Abdellatif M. Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res 2009; 104: 879-886 [PMID: 19265035 DOI: 10.1161/CIRCRESAHA.108.193102]
100. Yan W, Fang Z, Yang Q, Dong H, Lu Y, Lei C, Xiong L. SirT1 mediates hyperbaric oxygen preconditioning-induced ischemic tolerance in rat brain. J Cereb Blood Flow Metab 2013; 33: 396-406 [PMID: 23299244 DOI: 10.1038/jcbfm.2012.179]
101. Zaouali MA, Ben Mosbah I, Boncompagni E, Ben Abdennebi H, Mitjavila MT, Bartrons R, Freitas I, Rimola A, Roselló-Catafau J. Hypoxia inducible factor-1alpha accumulation in steatotic liver preservation: role of nitric oxide. World J Gastroenterol 2010; 16: 3499-3509 [PMID: 20653058]